A disruption in federal funds has jeopardized HIV testing and outreach in the U.S. South, and researchers warn of a ...

ABC News' Dr. Tara Narula breaks down a new study suggesting that a common HIV medication may significantly reduce the risk ...

In the face of a fear of loss of funds for ending the HIV/AIDS epidemic, activists in New Jersey walked to raise money.

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

On April 22, the CDC allegedly informed Emory University in Atlanta that its large HIV self-testing program was being ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

Patients attending Medway Maritime Hospital's A&E will now be routinely tested for HIV and hepatitis unless they opt out. The ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

A common medication used to treat HIV and hepatitis B may offer unexpected protection against Alzheimer's disease.

A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based ...

The South accounts for nearly half the nation's new HIV diagnoses. Prevention programs are trying to stem the tide, and in ...